Medicus Pharma Ltd. Common Stock (MDCXW)
SG&A Expense Growth
134.16%
Fiscal year · Period ending:
MDCXW SG&A Expense Growth
Latest reported134.16%period ending
Latest reported134.16%period ending
MDCXW FY SG&A Growth (YoY) (0.00% → 134.16%)
Latest values, visible window
High-resolution chart · PNG
MDCXW sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 134.1581% | |
| 210.4981% | |
| 642.3342% | |
| 28.6901% | |
| 0% |